The Program Committee selects the abstracts in advance of the Annual Meeting, and the track chair of each disease site/ section will act as a discussant to present abstracts in that session (original abstract authors are not invited to present).
The discussant’s role is to provide context to help better judge the importance of the abstracts within that section, compare and contrast the abstracts and highlight key points through their own presentation. They will use their expertise to guide an active discussion to show how the information may be relevant to the audience’s daily practice.
Abstract discussions, case studies will be presented, and faculty will answer audience questions. Open discussion is encouraged.